Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2R)-3-methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate is a synthetic small molecule compound with the molecular formula C18H27NO3 and a molecular weight of approximately 305.4 g/mol. It is listed in DrugBank as an experimental drug (DB07592) and has not been approved for any indication in the US or elsewhere. There are no reported clinical trials, patents, or marketed products associated with this compound. Its mechanism of action, pharmacological activity, therapeutic class, and potential indications have not been described in publicly available sources[7][10][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2R)-3-methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate.